Charles Naltet

Charles Naltet

UNVERIFIED PROFILE

Are you Charles Naltet?   Register this Author

Register author
Charles Naltet

Charles Naltet

Publications by authors named "Charles Naltet"

Are you Charles Naltet?   Register this Author

11Publications

316Reads

48Profile Views

The Emerging Role of CD8 Tissue Resident Memory T (T) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin.

Front Immunol 2018 15;9:1904. Epub 2018 Aug 15.

INSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, PSL, Fac. de Médecine - Univ. Paris-Sud, Université Paris-Saclay, Villejuif, France.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fimmu.2018.01904
Publisher Site
http://dx.doi.org/10.3389/fimmu.2018.01904DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104123PMC
September 2019

Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation.

Clin Lung Cancer 2018 01 3;19(1):e57-e61. Epub 2017 Aug 3.

Service d'Oncologie Thoracique, CIC-1425/CLIP(2) Paris-Nord, Université Paris-Diderot, Hôpital Bichat-Claude Bernard, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.07.003DOI Listing
January 2018

A review of bevacizumab in the treatment of malignant pleural mesothelioma.

Future Oncol 2017 Dec 20;13(28):2537-2546. Epub 2017 Sep 20.

Department of Thoracic Oncology & CIC 1425/CLIP2 Paris-Nord, Bichat-Claude Bernard Hospital, APHP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0307DOI Listing
December 2017

[Therapeutic advances in lung cancer].

Rev Prat 2017 01;67(1):47-50

Service d'oncologie thoracique, CIC1425/ CLIP2 Paris-Nord, université Paris- Diderot, hôpital Bichat-Claude-Bernard, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
January 2017

[Malignant pleural mesothelioma: rare and aggressive but with new therapeutic perspectives].

Rev Prat 2016 Feb;66(2):191-197

Service d'oncologie thoracique, hôpital Bichat- Claude Bernard, université Paris-Diderot, Paris, France.

View Article

Download full-text PDF

Source
February 2016

[Resistances to targeted therapies and strategy for following therapeutic lines in metastatic NSCLC].

Bull Cancer 2015 Jun;102(6 Suppl 1):S27-33

Service de pneumologie et oncologie thoracique, Université de Caen-Basse Normandie, Hôpital de la Côte-de-Nacre, 14033 Caen CS 3001, France; UMR Inserm 1086 Cancers et préventions, Université de Caen-Basse Normandie, Hôpital de la Côte-de-Nacre, 14033 Caen CS 3001, France; Centre de recherche clinique/Essais de phases précoces, Université de Caen-Basse Normandie, Hôpital de la Côte-de-Nacre, 14033 Caen CS 3001, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(15)31215-7DOI Listing
June 2015